Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Rodger

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 25, 2010
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trialSusan R Kahn, Ian Shrier, Stan Shapiro, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2023
The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolismLucia Caiano, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Blood Advances|November 29, 2018
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancyShannon M Bates, Anita Rajasekhar, Saskia Middeldorp, et al.
Blood Vessels, Thrombosis & Hemostasis|June 8, 2026
Impact of ABO blood groups on residual pulmonary vascular obstruction in patients with unprovoked pulmonary embolismFloriane Samaria, Ohanna C L Bezerra, Lénaïck Gourhant, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 30, 2008
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyMarc A Rodger, Susan R Kahn, Philip S Wells, et al.
BMJ (Clinical Research Ed.)|June 10, 2021
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J Kovacs, Philip S Wells, David R Anderson, et al.
BMJ (Clinical Research Ed.)|March 19, 2017
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyMarc A Rodger, Gregoire Le Gal, David R Anderson, et al.
The American Journal of Medicine|April 13, 2017
Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort StudySusan R Kahn, Arash Akaberi, John T Granton, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2021
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort studyDavid Aziz, Leslie Skeith, Marc A Rodger, et al.
Thrombosis and Haemostasis|September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort studyEsteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 25, 2010
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trialSusan R Kahn, Ian Shrier, Stan Shapiro, et al.
Journal of Thrombosis and Haemostasis : JTH|January 29, 2023
The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolismLucia Caiano, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Blood Advances|November 29, 2018
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancyShannon M Bates, Anita Rajasekhar, Saskia Middeldorp, et al.
Blood Vessels, Thrombosis & Hemostasis|June 8, 2026
Impact of ABO blood groups on residual pulmonary vascular obstruction in patients with unprovoked pulmonary embolismFloriane Samaria, Ohanna C L Bezerra, Lénaïck Gourhant, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 30, 2008
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyMarc A Rodger, Susan R Kahn, Philip S Wells, et al.
BMJ (Clinical Research Ed.)|June 10, 2021
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J Kovacs, Philip S Wells, David R Anderson, et al.
BMJ (Clinical Research Ed.)|March 19, 2017
Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyMarc A Rodger, Gregoire Le Gal, David R Anderson, et al.
The American Journal of Medicine|April 13, 2017
Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort StudySusan R Kahn, Arash Akaberi, John T Granton, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2021
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort studyDavid Aziz, Leslie Skeith, Marc A Rodger, et al.
Thrombosis and Haemostasis|September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort studyEsteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
Pageof 11